Should You Buy Intel Stock After a Nearly Fourfold Year?

Intel's Q2 revenue rose 25% year over year to $16.1 billion, while Data Center and AI operating income nearly quadrupled to $2.5 billion and segment revenue accelerated 59%. However, Intel Foundry still posted a $2.1 billion operating loss, with external foundry revenue only $293 million, and the company raised $23 billion through a 242 million-share issuance that lifted its share count roughly 20% year over year. At about $96 per share, Intel trades near 47x estimated next-year earnings versus roughly 20x for TSMC, leading the article to conclude that the stock already prices in substantial execution improvements.

Analysis

Intel’s rerating now rests on two separate underwriting assumptions: sustained AI/server product share gains and a credible path to foundry utilization. The first can support near-term estimates, but the second remains a capital-intensity problem rather than a revenue problem; incremental fab spending before third-party wafer commitments depresses free-cash-flow conversion and raises the hurdle for returns on invested capital. The recent equity issuance also means per-share earnings must compound materially faster than operating earnings to justify the premium multiple.

The more actionable relative-value implication is long TSM/short INTC. TSM monetizes industry-leading-node demand today, while Intel is valued on future process credibility and external-customer conversion that has not yet been independently demonstrated. Intel’s own internal demand can improve factory absorption, but it does not validate pricing, yield, or customer-service competitiveness versus TSM; a meaningful 14A anchor-customer announcement is the key falsifier for the short leg over the next 1-3 months.

Second-order beneficiaries are semiconductor equipment and substrate suppliers if Intel’s capex plan proceeds, but the allocation is selectively bullish rather than broadly bullish for the equipment complex: a delayed customer ramp could pull forward tool deliveries without producing durable wafer starts. FTNT’s relationship is strategically useful as a qualification reference but is too small to change Intel’s foundry economics; treating it as evidence of broad foundry traction would be a sentiment trap.

Consensus may be underestimating the probability of a sharp upside squeeze if server CPU supply tightens or a hyperscaler commits to 14A, but it is also likely underestimating the valuation sensitivity to one disappointing gross-margin or capex guide. Over 6-18 months, Intel needs external foundry revenue scaling from pilot levels into multi-billion-dollar annualized commitments, while losses narrow despite depreciation growth; absent that, the equity increasingly screens as a high-beta AI proxy with negative FCF optionality.

Key Decisions for Investors

• Initiate a 3-6 month relative-value position: long TSM / short INTC, sized beta-neutral. Target 15-25% relative return if Intel’s multiple normalizes toward profitable semiconductor peers; stop/reassess on a disclosed high-volume 14A customer or a material upward revision to 2027 EPS driven by external foundry orders.
• For directional Intel exposure, avoid unhedged short stock after the sharp rally; use a 3-6 month put spread financed partially with an out-of-the-money call spread. The thesis requires confirmation from the next earnings guide: rising capex without a proportional gross-margin or external-revenue outlook should pressure the shares.
• Maintain a watch item, not a trade, on FTNT: monitor whether the chip program moves from design win to volume qualification and whether it establishes an economics-relevant precedent for external customers. No position is warranted absent disclosed wafer volume, process economics, or follow-on customer commitments.
• Add TSM on any broad AI-semiconductor pullback rather than chase Intel momentum. TSM offers direct leading-edge volume leverage with less dependence on a turnaround execution narrative; reassess if advanced-node utilization weakens or major customers materially cut 2027 capex.